dx.doi.org/10.3324/haematol.2020.267831, hdl.handle.net/1765/133788
Haematologica
Department of Immunology

Bruinink, D.H.O., Oliva, S, Rihova, L., Schmitz, A, Gilestro, M., te Marvelde, J.G, … van der Velden, V.H.J. (2020). Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network. Haematologica, Online ahe. doi:10.3324/haematol.2020.267831